A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...

According to ophthalmologist Bradley Katz, PhD, the study’s lead author, vision issues are already a comorbidity related to diabetes. However, the GLP-1 medications might also be responsible for ...

After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...

As the FDA’s ban on mass compounding of semaglutide takes effect, Novo Nordisk introduces discounted pricing and new patient ...

The crackdown on off-brand weight loss and diabetes treatment drugs is about to take effect, meaning supplies for the treatments are likely to tighten.

Novo Nordisk boosts Wegovy access with discounts as FDA bans compounded semaglutide drugs and cracks down on weight-loss copycats.

New research confirms that just two days of eating a high-fat diet can compromise critical immune cells in the gut and weaken the intestinal barrier, suggesting the impact of our daily dietary choices ...

The Republican-controlled Federal Trade Commission has voted to dismiss a lawsuit against PepsiCo that the previous ...